Clinical trial
Clinical trial
on the use of mucopolysaccharides by athletes
Multicenter Trial / Spain
Specialities: Rheumatology, Orthopaedics, Sports Medicine
Clinical trial data
The population studied consisted of volunteers who had been previously informed about the trial.
No. of athletes: 204
Profile: - Women: 66
- Men: 138
- Average age: 32
- Athletes suffering from knee-cartilage injuries (knee pain from chondral injury).
Sports played: Bodybuilding, track and field, fitness training, team sports (soccer, baseball, basketball, handball, rugby, etc.), racket sports, martial arts, mountain sports, cycling, golf and horseback riding, among others.
Hours per week of training: 8
Date and place where the clinical trial was carried out: Spain, 2000.
Trial duration: Mucopolysaccharides (Bioibérica) taken for 3 months.
Administration: The doctor adapted the dosage taken by each patient in accordance with the level of injury.
Method
The clinical trial began with a first doctor's appointment, during which the patient's details were recorded: sex, age, weight, occupation, sport played, hours of training per week and history of previous sports injuries.
The doctor used the following measuring instruments to establish the clinical diagnosis for the patient: - Visual Analogue Scale (VAS) (to evaluate the level of pain).
- Lequesne Algofunctional Index (to measure movement capacity).
- Radiological diagnosis (Kellgren/Lawrence Scale).
The dosage to be taken by the athlete was then adapted in accordance with the extent of joint wear (chondral injury).
The trial was monitored through monthly doctor's appointments, during which the efficacy of treatment was evaluated by the doctor and the patient.
At the fourth and last appointment, a final assessment was made of the mucopolysaccharide-based nutritional supplement administered.
RESULTS
The results after the athletes had been taking mucopolysaccharides for three months showed a significant improvement (70%) in the athlete's functional capacity.
The functional capacity index measures the degree of difficulty of movement caused by wear on joint cartilage in certain common situations and at different times of the day.
Classification by sport: results SPORT | Beginning of Trial
MONTH 1
difficulty of movement index | End of Trial
MONTH 3
difficulty of movement index | bodybuilding / Martial arts | 8,44 | 3,63 | track and field | 6,43 | 1,69 | fitness training | 8,41 | 3,27 | team sports | 5,35 | 2,13 | mountain sports | 5,64 | 2,64 | racket sports | 7,5 | 2,05 | skiing | 5,5 | 1,07 | golf | 5 | 0 | horseback riding | 10 | 0 | swimming | 6 | 2,25 | other | 6,43 | 1,71 |
The table shows the sports played by the athletes that participated in the trial. The difficulty of movement was measured at the beginning of treatment and three months later, when the treatmentwas completed.
After treatment with mucopolysaccharides, considerable improvement was observed in the capacity of movement and the recovery of damaged cartilage.
85% of the athletes treated for 3 months with mucopolysaccharides (Bioibérica) thought the results were very positive.
88% of the doctors who participated in the trial confirmed the efficacy of Bioibérica mucopolysaccharides because of the good results observed in the patientstreated.
CONCLUSIONS
Injuries caused by overloading joints are becoming increasing common in sports medicine.
There are many conditions that can overload and put stress on joint cartilage. An increase in load frequency and intensity may explain why certain sports activities show a higher incidence of cartilage degeneration.
Therefore, daily supplements of mucopolysaccharides (Bioibérica) greatly contribute to improving joint cartilage and thus improve athletes' quality of life.
 |
|
